Drug-induced neuropsychiatric adverse events using post-marketing surveillance

CONCLUSION: Our results should raise physicians' awareness of drugs associated with abnormal behavior, but further investigation of these medications is warranted.PMID:33588740 | DOI:10.2174/1574884716666210215104540

Source: Current Clinical Pharmacology - February 16, 2021 Category: Drugs & Pharmacology Authors: Tomohito Wakabayashi Takahiro Nakatsuji Hiroko Kambara Iku Niinomi Saki Oyama Ayaka Inada Sayaka Ueno Mayako Uchida Kazunori Iwanaga Tatsuya Iida Keiko Hosohata Source Type: research